Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
New York City, NY, April 18, 2026 (GLOBE NEWSWIRE) -- You've done the diets. Probably more than once. You've tracked calories, cut carbs, tried intermittent fasting, started gym memberships in...
-
Brisbane City, Australia, April 18, 2026 (GLOBE NEWSWIRE) -- Introduction – What Is Strovemont Capital? Strovemont Capital is a modern digital trading platform designed to facilitate seamless...
-
Toronto City, Canada, April 18, 2026 (GLOBE NEWSWIRE) -- Introduction – What Is Bramridge Trust? Bramridge Trust is presented as a modern digital trading and investment infrastructure designed to...
-
Harmelo Introduces HMIN™ and HEIN™ Permanent System-Level Identifiers for Infrastructure That Has Never Had Them
-
$50 Million Federal Commitment to Ibogaine Research; Accelerates Pathway for Access to Life-Saving Treatments A Defining Moment for Brain Health Innovation in the United States AUSTIN, Texas, April ...
-
iCAUR V27 secures L3 off-road cert, proving robust new energy off-road capability.
-
ESCMID : Le Nuvaxovid, vaccin contre la COVID-19 de Sanofi, a montré une meilleure tolérance que le mNEXSPIKE dans une étude comparative directe Première étude comparative de phase 4, randomisée, en...
-
ESCMID: Sanofi's Nuvaxovid COVID-19 vaccine showed better tolerability than mNEXSPIKE in head-to-head study First head-to-head, double-blind, randomized phase 4 study powered to directly compare the...
-
ADAPT OCULUS is the first study to evaluate a targeted treatment for ocular MG, demonstrating that VYVGART significantly improves disease symptoms in this underserved patient populationADAPT SERON,...
-
Transaction in Own Shares 17 April 2026 • • • • • • • • • • • • • • • • Shell plc (the ‘Company’) announces that on 17 April 2026 it purchased the following number of Shares for cancellation. ...